Zhongzhu Healthcare HoldingLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Bo Anna Wang

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	5.1yrs

Recent management updates

Recent updates

CEO

Bo Anna Wang (60 yo)

no data

Tenure

Board Members

Name	Position	Tenure	Compensation	Ownership
Bao Long Qiao	VP & Director	5.1yrs	CN¥470.00k	no data
Jige Ye	Chairman	5.1yrs	CN¥1.43m	0.17% CN¥ 4.8m
Dong Mei Huang	Member of the Supervisory Board	no data	no data	no data
Jian Li	Member of the Supervisory Board	no data	no data	no data
Yi Bin Zeng	Independent Director	5.1yrs	no data	no data
Zhen Xin Yang	Independent Director	5.1yrs	no data	no data
Qin Xu	Employee Supervisor	3.7yrs	no data	no data
Lang Chen	Independent Director	no data	no data	no data

5.1yrs

Average Tenure

51.5yo

Average Age

Experienced Board: 600568's board of directors are considered experienced (5.1 years average tenure).

Zhongzhu Healthcare HoldingLtd Management

Management criteria checks 1/4

Key information

Recent management updates

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Insufficient new directors

Recent updates

First quarter 2024 earnings released: CN¥0.011 loss per share (vs CN¥0.014 loss in 1Q 2023)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.40 loss in FY 2022)

Zhongzhu Healthcare Holding Co.,Ltd, Annual General Meeting, May 08, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

Zhongzhu Healthcare Holding Co.,Ltd to Report Fiscal Year 2023 Results on Apr 17, 2024

Third quarter 2023 earnings released: CN¥0.008 loss per share (vs CN¥0.009 loss in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.011 loss in 2Q 2022)

Full year 2022 earnings released: CN¥0.40 loss per share (vs CN¥0.11 loss in FY 2021)

Third quarter 2022 earnings released: CN¥0.009 loss per share (vs CN¥0.008 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.011 loss per share (vs CN¥0.012 loss in 2Q 2021)

First quarter 2022 earnings released: CN¥0.002 loss per share (vs CN¥0.012 loss in 1Q 2021)

Full year 2021 earnings released: CN¥0.11 loss per share (vs CN¥0.002 profit in FY 2020)

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.005 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.012 loss per share (vs CN¥0.003 loss in 2Q 2020)

Jilin Zhongke Bio-engineering Joint Stock Co., Ltd. signed the share transfer agreement to acquire a 51% stake in Zhongzhu Zhongke Stem Cell Gene Technology Co., Ltd. from Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) for CNY 3 million.

Zeng Yamei won the bid and acquired 2.9% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from Zhuhai Zhongzhu Group Co., Ltd. for CNY 104.2 million.

Full year 2020 earnings released: EPS CN¥0.002 (vs CN¥0.18 loss in FY 2019)

Zhongzhu Healthcare's Shareholders to Sell 5.14% Stakes in the Company

New 90-day low: CN¥1.53

An unknown technology firm acquired 6.4% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568).

Xiao Feiying completed the acquisition of 6.26% stake in Zhongzhu Healthcare Holding Co.,Ltd (SHSE:600568) from the group of sellers.

Third quarter earnings released

Zhuhai Zhongzhu Co Ltd. agreed to be acquire the remaining 70.03% stake in Hubei Qianjiang Pharmaceutical Co., Ltd. (SHSE: 600568) in a reverse merger transaction .

First half earnings released

New 90-day high - CN¥1.50

Zhongzhu Healthcare Holding Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020

CEO

Tenure

Board Members

Average Tenure

Average Age